...
首页> 外文期刊>Antioxidants and redox signalling >Fus1/Tusc2 Is a Novel Regulator of Mitochondrial Calcium Handling, Ca2+-Coupled Mitochondrial Processes, and Ca2+-Dependent NFAT and NF-κB Pathways in CD4+ T Cells
【24h】

Fus1/Tusc2 Is a Novel Regulator of Mitochondrial Calcium Handling, Ca2+-Coupled Mitochondrial Processes, and Ca2+-Dependent NFAT and NF-κB Pathways in CD4+ T Cells

机译:Fus1 / TUSC2是CD4 + T细胞中的线粒体钙处理,CA2 +耦合线粒体过程和CA2 +依赖性NFAT和NF-κB途径的新型调节器

获取原文
获取原文并翻译 | 示例
           

摘要

AbstractAims: Fus1 has been established as mitochondrial tumor suppressor, immunomodulator, and antioxidant protein, but molecular mechanism of these activities remained to be identified. Based on putative calcium-binding and myristoyl-binding domains that we identified in Fus1, we explored our hypothesis that Fus1 regulates mitochondrial calcium handling and calcium-coupled processes. Results: Fus1 loss resulted in reduced rate of mitochondrial calcium uptake in calcium-loaded epithelial cells, splenocytes, and activated CD4+ T cells. The reduced rate of mitochondrial calcium uptake in Fus1-deficient cells correlated with cytosolic calcium increase and dysregulation of calcium-coupled mitochondrial parameters, such as reactive oxygen species production, ΔμH+, mitochondrial permeability transition pore opening, and GSH content. Inhibition of calcium efflux via mitochondria, Na+/Ca2+ exchanger significantly improved the mitochondrial calcium uptake in Fus1?/? cells. Ex vivo analysis of activated CD4+ T cells showed Fus1-dependent changes in calcium-regulated processes, such as surface expression of CD4 and PD1/PD-L1, proliferation, and Th polarization. Fus1?/? T cells showed increased basal expression of calcium-dependent NF-κB and NFAT targets but were unable to fully activate these pathways after stimulation. Innovation: Our results establish Fus1 as one of the few identified regulators of mitochondrial calcium handling. Our data support the idea that alterations in mitochondrial calcium dynamics could lead to the disruption of metabolic coupling in mitochondria that, in turn, may result in multiple cellular and systemic abnormalities. Conclusion: Our findings suggest that Fus1 achieves its protective role in inflammation, autoimmunity, and cancer via the regulation of mitochondrial calcium and calcium-coupled parameters.
机译:提示事宜:FUS1已建立为线粒体肿瘤抑制剂,免疫调节剂和抗氧化蛋白,但这些活动的分子机制仍有待定。基于我们在FUS1中鉴定的推定钙结合和MyRistoyl结合结构域,我们探讨了FUS1调节线粒体钙处理和钙耦合过程的假设。结果:FUS1损失导致钙加载上皮细胞,脾细胞和活化CD4 + T细胞的线粒体钙吸收率降低。与细胞溶质钙的细胞的线粒体钙摄取率降低,与钙偶联线粒体参数的胞质钙升高和钙偶联线粒体参数的失调,例如反应性氧物质生产,ΔμH+,线粒体渗透率过渡孔开口和GSH含量。通过线粒体,Na + / Ca2 +交换器抑制钙渗透,纳+ / Ca2 +交换器显着改善了FUS1中的线粒体钙吸收?/?细胞。活化CD4 + T细胞的前体内分析显示钙调节过程的FUS1依赖性变化,例如CD4和PD1 / PD-L1的表面表达,增殖和Th偏振。 fus1?/? T细胞显示钙依赖性NF-κB和NFAT靶标的基础表达增加,但在刺激后无法完全激活这些途径。创新:我们的结果建立了FUS1作为线粒体钙处理的少数识别的稳压器之一。我们的数据支持想法,即线粒体钙动力学的改变可能导致线粒体中的代谢偶联中断,又可能导致多种细胞和系统性异常。结论:我们的研究结果表明,Fus1通过调节线粒体钙和钙偶联参数来实现其在炎症,自身免疫和癌症中的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号